Skip to content
Axcess News – Lifestyle
Author:
Benjamin Berkowitz Texas
Autobahn Therapeutics Announces U.S. FDA Fast Track Designation for Elunetirom, a CNS-Directed Thyroid Hormone Receptor Agonist, for the Adjunctive Treatment of Bipolar Depression
May 26, 2026
DATROWAY® (datopotamab deruxtecan-dlnk) approved in the US as first TROP2-directed antibody drug conjugate for 1st-line treatment of patients with metastatic triple-negative breast cancer who are not PD-1/PD-L1 inhibitor candidates
May 26, 2026
Datroway® Approved in the U.S. as First TROP2 Directed Antibody Drug Conjugate for First-Line Treatment of Patients with Metastatic Triple Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
May 26, 2026
LIB Therapeutics Announces Results from Presentations on LEROCHOL® (lerodalcibep-liga) at the 2026 European Atherosclerosis Society Meeting in Athens, May 24-26, 2026
May 26, 2026
Alkermes to Showcase Leadership in Psychiatry and Orexin Biology With New Data at the American Society of Clinical Psychopharmacology Annual Meeting
May 26, 2026
Champion Homes Announces Fourth Quarter and Full Year Fiscal 2026 Results
May 26, 2026
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Cisplatin-Ineligible Resectable Muscle-Invasive Bladder Cancer
May 26, 2026
Nachawati Law Group’s Ann Saucer Appointed to Leadership Role in Consolidated Sexual Assault Litigation Against Lyft
May 26, 2026
BBRC Corrects the Record on Victoria’s Secret’s Investor Presentation
May 26, 2026
BJ’s Wholesale Club Holdings, Inc. Announces First Quarter Fiscal 2026 Results
May 26, 2026
←
Previous Page
1
…
15
16
17
18
19
…
128
Next Page
→